首页 > 最新文献

Journal of Endocrinological Investigation最新文献

英文 中文
The acromegalic? Giant Samuel MacDonald and the short stature George Cranstoun by John Kay. 肢端肥大症患者?约翰·凯的巨人塞缪尔·麦克唐纳和身材矮小的乔治·克兰斯顿。
IF 5.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-09-01 Epub Date: 2021-11-29 DOI: 10.1007/s40618-021-01716-z
W de Herder
{"title":"The acromegalic? Giant Samuel MacDonald and the short stature George Cranstoun by John Kay.","authors":"W de Herder","doi":"10.1007/s40618-021-01716-z","DOIUrl":"https://doi.org/10.1007/s40618-021-01716-z","url":null,"abstract":"","PeriodicalId":15651,"journal":{"name":"Journal of Endocrinological Investigation","volume":"45 9","pages":"1805-1806"},"PeriodicalIF":5.4,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39943056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Goiter in a Fresco by Giovanni Luigi Valesio (1611, Church of Saints Eusebio and Vittore, Peglio, Como). 乔瓦尼·路易吉·瓦莱西奥(Giovanni Luigi Valesio)壁画中的甲状腺肿(1611年,圣尤西比奥和维托尔教堂,佩格里奥,科莫)。
IF 5.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-09-01 Epub Date: 2021-09-21 DOI: 10.1007/s40618-021-01678-2
G Dionigi, R Dionigi

In the Fresco, "Faith and Its Fight Against Heresy (1611, Church of Saints Eusebio and Vittore, Peglio, Como)" is depicted as an old woman with 'scattered and steep hairs', ugly and physically in poor condition, also due to the presence of a voluminous goiter.

在这幅壁画中,“信仰及其与异端的斗争(1611年,科摩佩格利奥圣尤西比奥和维托尔教堂)”被描绘成一位“头发分散而陡峭”的老妇人,丑陋,身体状况不佳,也是因为有一个巨大的甲状腺肿。
{"title":"Goiter in a Fresco by Giovanni Luigi Valesio (1611, Church of Saints Eusebio and Vittore, Peglio, Como).","authors":"G Dionigi,&nbsp;R Dionigi","doi":"10.1007/s40618-021-01678-2","DOIUrl":"https://doi.org/10.1007/s40618-021-01678-2","url":null,"abstract":"<p><p>In the Fresco, \"Faith and Its Fight Against Heresy (1611, Church of Saints Eusebio and Vittore, Peglio, Como)\" is depicted as an old woman with 'scattered and steep hairs', ugly and physically in poor condition, also due to the presence of a voluminous goiter.</p>","PeriodicalId":15651,"journal":{"name":"Journal of Endocrinological Investigation","volume":"45 9","pages":"1801-1803"},"PeriodicalIF":5.4,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39456835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between telemedicine use and diabetes risk factor assessment and control in a primary care network. 远程医疗的使用与初级保健网络中糖尿病风险因素评估和控制之间的关系
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-09-01 Epub Date: 2022-05-21 DOI: 10.1007/s40618-022-01814-6
A Grauer, A T Duran, N A Liyanage-Don, L M Torres-Deas, G Metser, N Moise, I M Kronish, S Ye

Purpose: Our study examined whether telemedicine use in primary care is associated with risk factor assessment and control for patients with diabetes mellitus.

Methods: This was a retrospective, 1:1 propensity score matched cohort study conducted in a primary care network between February 2020 and December 2020. Participants included patients with diabetes mellitus, ages 18 to 75. Exposure of interest was any telemedicine visit. We determined whether hemoglobin A1c (HbA1c), blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) were assessed for each patient. For each risk factor, we also determined whether the risk factor was controlled when they were assessed (i.e., last HbA1c < 8.0%, BP < 130/80 mmHg, LDL-C < 100 mg/dL).

Results: After 1:1 propensity score matching, we identified 1,824 patients with diabetes during the study period. Telemedicine use was associated with a lower proportion of patients with all three risk factors assessed (162/912 [18%], versus 408/912 [45%], p < 0.001). However, when individual risk factors were assessed, telemedicine use did not impact risk factor control. When compared with patients with in-person visit only, the odds ratio (OR) for HbA1c < 8% was 1.04 (95% CI 0.74 to 1.46, p = 0.23) for patients with any telemedicine visit. Similarly, the OR for BP < 130/80 mmHg was 1.08 (95% CI 0.85-1.36 p = 0.53), and the OR for LDL-C < 100 mg/dL was 1.14 (95% CI 0.76-1.72, p = 0.52).

Conclusions: Telemedicine use was associated with gaps in risk factor assessment for patients with diabetes during the COVID-19 pandemic, but had limited impact on whether risk factors were controlled.

目的:我们的研究探讨了初级医疗中远程医疗的使用是否与糖尿病患者的风险因素评估和控制有关:这是一项回顾性、1:1倾向得分匹配队列研究,于 2020 年 2 月至 2020 年 12 月期间在一个初级保健网络中进行。参与者包括 18 至 75 岁的糖尿病患者。研究对象为任何一次远程医疗就诊。我们确定是否对每位患者的血红蛋白 A1c (HbA1c)、血压 (BP) 和低密度脂蛋白胆固醇 (LDL-C) 进行了评估。对于每个风险因素,我们还确定了评估时风险因素是否得到控制(即最后一次 HbA1c 结果):经过 1:1 倾向评分匹配,我们确定了研究期间的 1,824 名糖尿病患者。使用远程医疗与全部三个风险因素均得到评估的患者比例较低有关(162/912 [18%]对 408/912 [45%],P 结论:使用远程医疗与全部三个风险因素均得到评估的患者比例较低有关:在 COVID-19 大流行期间,远程医疗的使用与糖尿病患者风险因素评估的差距有关,但对风险因素是否得到控制的影响有限。
{"title":"Association between telemedicine use and diabetes risk factor assessment and control in a primary care network.","authors":"A Grauer, A T Duran, N A Liyanage-Don, L M Torres-Deas, G Metser, N Moise, I M Kronish, S Ye","doi":"10.1007/s40618-022-01814-6","DOIUrl":"10.1007/s40618-022-01814-6","url":null,"abstract":"<p><strong>Purpose: </strong>Our study examined whether telemedicine use in primary care is associated with risk factor assessment and control for patients with diabetes mellitus.</p><p><strong>Methods: </strong>This was a retrospective, 1:1 propensity score matched cohort study conducted in a primary care network between February 2020 and December 2020. Participants included patients with diabetes mellitus, ages 18 to 75. Exposure of interest was any telemedicine visit. We determined whether hemoglobin A1c (HbA1c), blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) were assessed for each patient. For each risk factor, we also determined whether the risk factor was controlled when they were assessed (i.e., last HbA1c < 8.0%, BP < 130/80 mmHg, LDL-C < 100 mg/dL).</p><p><strong>Results: </strong>After 1:1 propensity score matching, we identified 1,824 patients with diabetes during the study period. Telemedicine use was associated with a lower proportion of patients with all three risk factors assessed (162/912 [18%], versus 408/912 [45%], p < 0.001). However, when individual risk factors were assessed, telemedicine use did not impact risk factor control. When compared with patients with in-person visit only, the odds ratio (OR) for HbA1c < 8% was 1.04 (95% CI 0.74 to 1.46, p = 0.23) for patients with any telemedicine visit. Similarly, the OR for BP < 130/80 mmHg was 1.08 (95% CI 0.85-1.36 p = 0.53), and the OR for LDL-C < 100 mg/dL was 1.14 (95% CI 0.76-1.72, p = 0.52).</p><p><strong>Conclusions: </strong>Telemedicine use was associated with gaps in risk factor assessment for patients with diabetes during the COVID-19 pandemic, but had limited impact on whether risk factors were controlled.</p>","PeriodicalId":15651,"journal":{"name":"Journal of Endocrinological Investigation","volume":"45 1","pages":"1749-1756"},"PeriodicalIF":3.9,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123919/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49506500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The potential impact of COVID-19 on male reproductive health. COVID-19对男性生殖健康的潜在影响。
IF 5.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-08-01 Epub Date: 2022-02-18 DOI: 10.1007/s40618-022-01764-z
T T Nguyen, J Hulme, H D Tran, T K Vo, G V Vo

The SARS-CoV-2 virus continues to overwhelm health care systems impairing human to human social and economic interactions. Invasion or damage to the male reproductive system is one of the documented outcomes of viral infection. Existing studies have reported that SARS-CoV-2 may contribute to this loss in relation to inflammatory responses and the formation of cytokine storms in COVID-19 patients. Although direct infection of the testes and entry of SARS-CoV-2 into semen as well as subsequent consequences on the male reproductive system need to be studied more systematically, warnings from two organising ASRM and SART for prospective parents when infected with SARS-CoV-2 should be considered. In the context of an increasingly complex pandemic, this review provides preliminary examples of the potential impact of COVID-19 on male reproductive health and guidance for prospective parents currently infected with or recovering from SARS-CoV-2.

SARS-CoV-2病毒继续使卫生保健系统不堪重负,损害人与人之间的社会和经济互动。入侵或损害男性生殖系统是有记载的病毒感染的结果之一。现有研究报道,SARS-CoV-2可能导致这种损失,与COVID-19患者的炎症反应和细胞因子风暴的形成有关。尽管需要更系统地研究睾丸直接感染和SARS-CoV-2进入精液及其对男性生殖系统的后续影响,但应考虑两个组织ASRM和SART对感染SARS-CoV-2的准父母的警告。在疫情日益复杂的背景下,本综述提供了COVID-19对男性生殖健康潜在影响的初步示例,并为目前感染或正在康复的潜在父母提供了指导。
{"title":"The potential impact of COVID-19 on male reproductive health.","authors":"T T Nguyen,&nbsp;J Hulme,&nbsp;H D Tran,&nbsp;T K Vo,&nbsp;G V Vo","doi":"10.1007/s40618-022-01764-z","DOIUrl":"https://doi.org/10.1007/s40618-022-01764-z","url":null,"abstract":"<p><p>The SARS-CoV-2 virus continues to overwhelm health care systems impairing human to human social and economic interactions. Invasion or damage to the male reproductive system is one of the documented outcomes of viral infection. Existing studies have reported that SARS-CoV-2 may contribute to this loss in relation to inflammatory responses and the formation of cytokine storms in COVID-19 patients. Although direct infection of the testes and entry of SARS-CoV-2 into semen as well as subsequent consequences on the male reproductive system need to be studied more systematically, warnings from two organising ASRM and SART for prospective parents when infected with SARS-CoV-2 should be considered. In the context of an increasingly complex pandemic, this review provides preliminary examples of the potential impact of COVID-19 on male reproductive health and guidance for prospective parents currently infected with or recovering from SARS-CoV-2.</p>","PeriodicalId":15651,"journal":{"name":"Journal of Endocrinological Investigation","volume":"45 8","pages":"1483-1495"},"PeriodicalIF":5.4,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856879/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39936924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Clinical and radiological presentation of parasellar ectopic pituitary adenomas: case series and systematic review of the literature. 鞍旁异位垂体腺瘤的临床和影像学表现:病例系列和文献的系统回顾。
IF 5.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-08-01 Epub Date: 2022-02-11 DOI: 10.1007/s40618-022-01758-x
C Campana, F Nista, L Castelletti, M Caputo, E Lavezzi, P Marzullo, A Ferrero, G Gaggero, F R Canevari, D C Rossi, G Zona, A Lania, D Ferone, F Gatto

Purpose: Parasellar ectopic pituitary adenomas (pEPAs) are extremely rare tumors located out of the sella turcica. PEPAs are heterogeneous entities in terms of anatomical localization and secretion of anterior pituitary hormones.

Methods: Multicenter retrospective study. Clinical charts' consultation of patients diagnosed with parasellar lesions, to identify all subjects fulfilling the diagnostic criteria of parasellar EPAs. Systematic review of the literature focused on the medical management of prolactin-secreting pEPAs and on the prevalence of radiological bone invasion in pEPAs.

Results: We identified four cases of pEPAs: (1) 54-year-old female with a prolactin-secreting suprasellar EPA successfully treated with cabergoline; (2) 74-year-old male with a non-functioning EPA of the sphenoidal sinus treated with endoscopic transsphenoidal surgery; (3) 75-year-old female with a giant lesion of the skull base (maximum diameter 7.2 cm) diagnosed as a non-functioning EPA after biopsy; (4) 49-year-old male with a silent corticotroph EPA of the sphenoidal sinus and clivus. Three out of four cases had radiological evidence of invasion of the surrounding bone structures. A systematic review of the literature highlighted that medical therapy can be effective in prolactin-secreting pEPAs. Overall, we found mention of local invasiveness in 65/147 cases (44.2%), confirmed by radiological signs of bone invasion/erosion.

Conclusion: Our experience confirms the heterogeneity of pEPAs in terms of clinical and radiological presentation, as well as hormone secretion. PEPAs show a high frequency of radiological bone invasion, though similar to that of sellar pituitary adenomas. Although extremely rare, pEPAs need to be considered in the differential diagnosis of parasellar lesions.

目的:鞍旁异位垂体腺瘤是一种位于鞍外的极为罕见的肿瘤。在解剖定位和垂体前叶激素分泌方面,PEPAs是异质实体。方法:多中心回顾性研究。对诊断为鞍旁病变的患者进行临床图表会诊,以确定所有符合鞍旁病变诊断标准的受试者。系统回顾文献的重点是催乳素分泌pEPAs的医疗管理和pEPAs的放射性骨侵犯的患病率。结果:我们发现了4例pEPAs病例:(1)54岁女性与催乳素分泌上鞍EPA成功治疗卡麦角林;(2) 74岁男性,蝶窦功能不全,经内镜蝶窦手术治疗;(3) 75岁女性,颅底巨大病变(最大直径7.2 cm),活检诊断为无功能EPA;(4) 49岁男性,蝶窦及斜坡无症状性皮质性EPA。四分之三的病例有放射学证据表明周围骨结构受到侵犯。一项系统的文献综述强调,药物治疗可以有效地促进泌乳素分泌的pEPAs。总体而言,147例病例中有65例(44.2%)发现有局部浸润,并有骨浸润/侵蚀的影像学征象。结论:我们的经验证实了pEPAs在临床和影像学表现以及激素分泌方面的异质性。尽管与垂体鞍腺瘤相似,但pepa表现出高频率的影像学骨侵犯。尽管极为罕见,但在鞍旁病变的鉴别诊断中仍需考虑pepa。
{"title":"Clinical and radiological presentation of parasellar ectopic pituitary adenomas: case series and systematic review of the literature.","authors":"C Campana,&nbsp;F Nista,&nbsp;L Castelletti,&nbsp;M Caputo,&nbsp;E Lavezzi,&nbsp;P Marzullo,&nbsp;A Ferrero,&nbsp;G Gaggero,&nbsp;F R Canevari,&nbsp;D C Rossi,&nbsp;G Zona,&nbsp;A Lania,&nbsp;D Ferone,&nbsp;F Gatto","doi":"10.1007/s40618-022-01758-x","DOIUrl":"https://doi.org/10.1007/s40618-022-01758-x","url":null,"abstract":"<p><strong>Purpose: </strong>Parasellar ectopic pituitary adenomas (pEPAs) are extremely rare tumors located out of the sella turcica. PEPAs are heterogeneous entities in terms of anatomical localization and secretion of anterior pituitary hormones.</p><p><strong>Methods: </strong>Multicenter retrospective study. Clinical charts' consultation of patients diagnosed with parasellar lesions, to identify all subjects fulfilling the diagnostic criteria of parasellar EPAs. Systematic review of the literature focused on the medical management of prolactin-secreting pEPAs and on the prevalence of radiological bone invasion in pEPAs.</p><p><strong>Results: </strong>We identified four cases of pEPAs: (1) 54-year-old female with a prolactin-secreting suprasellar EPA successfully treated with cabergoline; (2) 74-year-old male with a non-functioning EPA of the sphenoidal sinus treated with endoscopic transsphenoidal surgery; (3) 75-year-old female with a giant lesion of the skull base (maximum diameter 7.2 cm) diagnosed as a non-functioning EPA after biopsy; (4) 49-year-old male with a silent corticotroph EPA of the sphenoidal sinus and clivus. Three out of four cases had radiological evidence of invasion of the surrounding bone structures. A systematic review of the literature highlighted that medical therapy can be effective in prolactin-secreting pEPAs. Overall, we found mention of local invasiveness in 65/147 cases (44.2%), confirmed by radiological signs of bone invasion/erosion.</p><p><strong>Conclusion: </strong>Our experience confirms the heterogeneity of pEPAs in terms of clinical and radiological presentation, as well as hormone secretion. PEPAs show a high frequency of radiological bone invasion, though similar to that of sellar pituitary adenomas. Although extremely rare, pEPAs need to be considered in the differential diagnosis of parasellar lesions.</p>","PeriodicalId":15651,"journal":{"name":"Journal of Endocrinological Investigation","volume":"45 8","pages":"1465-1481"},"PeriodicalIF":5.4,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39909575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
An update on thyroid disorders in the postpartum period. 产后甲状腺疾病的最新进展。
IF 5.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-08-01 Epub Date: 2022-02-18 DOI: 10.1007/s40618-022-01762-1
C C-H Peng, E N Pearce

Purpose: To review the pathophysiology, diagnosis and management of postpartum thyroid dysfunction, and related management of thyroid disorders during lactation.

Methods: We reviewed the literature on postpartum thyroid dysfunction and management of thyroid disorders during lactation.

Results: The postpartum period is characterized by a rebound from the immunotolerance induced by pregnancy. Routine thyroid function screening is not recommended for asymptomatic women in the postpartum period. Testing thyroid function should be considered at 6-12-week postpartum for high-risk populations, including women with a previous episode of postpartum thyroiditis, Graves' disease, or those with Hashimoto's thyroiditis on thyroid hormone replacement, known thyroid peroxidase antibody positivity, type 1 diabetes mellitus, other nonthyroidal autoimmune disease, or chronic hepatitis C. A serum TSH should also be checked in the setting of postpartum depression or difficulty lactating. If patients have thyrotoxicosis, new-onset or recurrent Graves' disease must be differentiated from postpartum thyroiditis, because the management differs. Periodic thyroid function testing is recommended following recovery from postpartum thyroiditis due to high lifetime risk of developing permanent hypothyroidism. Levothyroxine, and the lowest effective dose of antithyroid drugs, (propylthiouracil, methimazole, and carbimazole) can be safely used in lactating women. The use of radiopharmaceutical scanning is avoided during lactation and radioactive iodine treatment is contraindicated.

Conclusions: Diagnosing postpartum thyroid dysfunction is challenging, because symptoms may be subtle. A team approach involving primary care providers, endocrinologists, and obstetricians is essential for transitioning thyroid care from the gestational to the postpartum setting.

目的:综述产后甲状腺功能障碍的病理生理、诊断和处理,以及哺乳期甲状腺功能障碍的相关处理。方法:回顾有关产后甲状腺功能障碍及哺乳期甲状腺功能障碍处理的文献。结果:产后以妊娠引起的免疫耐受反弹为特征。产后无症状妇女不建议常规甲状腺功能筛查。高危人群应在产后6-12周检查甲状腺功能,包括有产后甲状腺炎、Graves病、桥本甲状腺炎、甲状腺激素替代、已知甲状腺过氧化物酶抗体阳性、1型糖尿病、其他非甲状腺自身免疫性疾病或慢性丙型肝炎的妇女。在产后抑郁或泌乳困难的情况下,也应检查血清TSH。如果患者有甲状腺毒症,新发或复发的格雷夫斯病必须与产后甲状腺炎相鉴别,因为处理方法不同。由于发生永久性甲状腺功能减退的高风险,建议在产后甲状腺炎恢复后进行定期甲状腺功能检查。左甲状腺素和最低有效剂量的抗甲状腺药物(丙硫脲嘧啶、甲巯咪唑和卡咪唑)可以安全地用于哺乳期妇女。哺乳期避免使用放射性药物扫描,禁止放射性碘治疗。结论:诊断产后甲状腺功能障碍具有挑战性,因为症状可能很微妙。一个包括初级保健提供者、内分泌学家和产科医生的团队方法对于将甲状腺护理从妊娠期过渡到产后是必不可少的。
{"title":"An update on thyroid disorders in the postpartum period.","authors":"C C-H Peng,&nbsp;E N Pearce","doi":"10.1007/s40618-022-01762-1","DOIUrl":"https://doi.org/10.1007/s40618-022-01762-1","url":null,"abstract":"<p><strong>Purpose: </strong>To review the pathophysiology, diagnosis and management of postpartum thyroid dysfunction, and related management of thyroid disorders during lactation.</p><p><strong>Methods: </strong>We reviewed the literature on postpartum thyroid dysfunction and management of thyroid disorders during lactation.</p><p><strong>Results: </strong>The postpartum period is characterized by a rebound from the immunotolerance induced by pregnancy. Routine thyroid function screening is not recommended for asymptomatic women in the postpartum period. Testing thyroid function should be considered at 6-12-week postpartum for high-risk populations, including women with a previous episode of postpartum thyroiditis, Graves' disease, or those with Hashimoto's thyroiditis on thyroid hormone replacement, known thyroid peroxidase antibody positivity, type 1 diabetes mellitus, other nonthyroidal autoimmune disease, or chronic hepatitis C. A serum TSH should also be checked in the setting of postpartum depression or difficulty lactating. If patients have thyrotoxicosis, new-onset or recurrent Graves' disease must be differentiated from postpartum thyroiditis, because the management differs. Periodic thyroid function testing is recommended following recovery from postpartum thyroiditis due to high lifetime risk of developing permanent hypothyroidism. Levothyroxine, and the lowest effective dose of antithyroid drugs, (propylthiouracil, methimazole, and carbimazole) can be safely used in lactating women. The use of radiopharmaceutical scanning is avoided during lactation and radioactive iodine treatment is contraindicated.</p><p><strong>Conclusions: </strong>Diagnosing postpartum thyroid dysfunction is challenging, because symptoms may be subtle. A team approach involving primary care providers, endocrinologists, and obstetricians is essential for transitioning thyroid care from the gestational to the postpartum setting.</p>","PeriodicalId":15651,"journal":{"name":"Journal of Endocrinological Investigation","volume":"45 8","pages":"1497-1506"},"PeriodicalIF":5.4,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39936922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD. NAFLD患者的外周动脉疾病与全因和心血管死亡率
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-08-01 Epub Date: 2022-04-02 DOI: 10.1007/s40618-022-01792-9
S Ciardullo, E Bianconi, R Cannistraci, P Parmeggiani, E M Marone, G Perseghin

Purpose: Cardiovascular disease (CVD) is the first cause of death in patients with non-alcoholic fatty liver disease (NAFLD) and risk stratification is recommended by current guidelines. The aim of this study is to assess the prevalence of peripheral arterial disease (PAD) in patients with NAFLD and its association with all-cause and cardiovascular disease (CVD) mortality.

Methods: 9145 participants 40 years or older attended a mobile examination center visit in the 1999-2004 cycles of the National Health and Nutrition Examination Survey. PAD was defined as an ankle-brachial index (ABI) < 0.90 in either of the legs and mortality data through December 2015 were obtained from the National Death Index. NAFLD was defined by a fatty liver index ≥ 60 in the absence of other liver conditions, leading to a final sample of 3094 subjects.

Results: The overall prevalence of PAD was 5.9% (95% CI 5.0-6.9). Over a median follow-up of 13 years, 876 participants died, 208 of cardiovascular causes. Incidence rates of all-cause mortality (for 1000 person-years) were 20.2 (95% CI 18.7-21.7) and 70.0 (95% CI 60.1-81.6) for participants without and with PAD, respectively. Multivariable-adjusted Cox proportional hazard models showed that PAD was associated with a higher risk of all-cause (1.8, 95% CI 1.4-2.4) and cardiovascular mortality (HR 2.5, 95% CI 1.5-4.3) after adjustment for potential confounders including prevalent CVD.

Conclusion: Current guidelines strongly encourage the screening of CVD in patients with NAFLD and the use of the simple and inexpensive measurement of ABI in routine clinical practice may find indication.

目的:心血管疾病(CVD)是非酒精性脂肪肝(NAFLD)患者的首要死因,现行指南建议对患者进行风险分层。本研究的目的是评估非酒精性脂肪肝患者中外周动脉疾病(PAD)的患病率及其与全因死亡率和心血管疾病(CVD)死亡率的关系。方法:9145 名 40 岁及以上的参与者参加了 1999-2004 年周期性全国健康与营养调查的流动检查中心访问。PAD的定义是踝肱指数(ABI)结果:PAD的总患病率为5.9%(95% CI为5.0-6.9)。在13年的中位随访中,876名参与者死亡,其中208人死于心血管疾病。无 PAD 和 PAD 患者的全因死亡率(千人年)分别为 20.2(95% CI 18.7-21.7)和 70.0(95% CI 60.1-81.6)。多变量调整后的考克斯比例危险模型显示,在调整了包括流行性心血管疾病在内的潜在混杂因素后,PAD与较高的全因死亡风险(1.8,95% CI 1.4-2.4)和心血管死亡风险(HR 2.5,95% CI 1.5-4.3)相关:结论:目前的指南大力鼓励对非酒精性脂肪肝患者进行心血管疾病筛查,在常规临床实践中使用简单、廉价的 ABI 测量方法可能会找到适应症。
{"title":"Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD.","authors":"S Ciardullo, E Bianconi, R Cannistraci, P Parmeggiani, E M Marone, G Perseghin","doi":"10.1007/s40618-022-01792-9","DOIUrl":"10.1007/s40618-022-01792-9","url":null,"abstract":"<p><strong>Purpose: </strong>Cardiovascular disease (CVD) is the first cause of death in patients with non-alcoholic fatty liver disease (NAFLD) and risk stratification is recommended by current guidelines. The aim of this study is to assess the prevalence of peripheral arterial disease (PAD) in patients with NAFLD and its association with all-cause and cardiovascular disease (CVD) mortality.</p><p><strong>Methods: </strong>9145 participants 40 years or older attended a mobile examination center visit in the 1999-2004 cycles of the National Health and Nutrition Examination Survey. PAD was defined as an ankle-brachial index (ABI) < 0.90 in either of the legs and mortality data through December 2015 were obtained from the National Death Index. NAFLD was defined by a fatty liver index ≥ 60 in the absence of other liver conditions, leading to a final sample of 3094 subjects.</p><p><strong>Results: </strong>The overall prevalence of PAD was 5.9% (95% CI 5.0-6.9). Over a median follow-up of 13 years, 876 participants died, 208 of cardiovascular causes. Incidence rates of all-cause mortality (for 1000 person-years) were 20.2 (95% CI 18.7-21.7) and 70.0 (95% CI 60.1-81.6) for participants without and with PAD, respectively. Multivariable-adjusted Cox proportional hazard models showed that PAD was associated with a higher risk of all-cause (1.8, 95% CI 1.4-2.4) and cardiovascular mortality (HR 2.5, 95% CI 1.5-4.3) after adjustment for potential confounders including prevalent CVD.</p><p><strong>Conclusion: </strong>Current guidelines strongly encourage the screening of CVD in patients with NAFLD and the use of the simple and inexpensive measurement of ABI in routine clinical practice may find indication.</p>","PeriodicalId":15651,"journal":{"name":"Journal of Endocrinological Investigation","volume":"45 1","pages":"1547-1553"},"PeriodicalIF":3.9,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270293/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42767100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Goiter in a fresco by simone peterzano, master of caravaggio (1578-1582, Garegnano Charterhouse, Milan). 卡拉瓦乔的大师西蒙娜·彼得扎诺(1578-1582,米兰加雷尼亚诺·查特豪斯)的一幅壁画。
IF 5.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-08-01 Epub Date: 2021-09-03 DOI: 10.1007/s40618-021-01670-w
G Dionigi, R Dionigi

Simone Peterzano mostly known as the master of Caravaggio executed frescoes in the presbytery of Garegnano Charterhouse. One fresco details a shepherd with a goiter.

西蒙娜·彼得扎诺,最著名的卡拉瓦乔大师,在加列尼亚诺修道院的长老会里创作了壁画。其中一幅壁画描绘了一个甲状腺肿大的牧羊人。
{"title":"Goiter in a fresco by simone peterzano, master of caravaggio (1578-1582, Garegnano Charterhouse, Milan).","authors":"G Dionigi,&nbsp;R Dionigi","doi":"10.1007/s40618-021-01670-w","DOIUrl":"https://doi.org/10.1007/s40618-021-01670-w","url":null,"abstract":"<p><p>Simone Peterzano mostly known as the master of Caravaggio executed frescoes in the presbytery of Garegnano Charterhouse. One fresco details a shepherd with a goiter.</p>","PeriodicalId":15651,"journal":{"name":"Journal of Endocrinological Investigation","volume":"45 8","pages":"1607-1608"},"PeriodicalIF":5.4,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39381913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Mystery of love, goiter and death in flu pandemic. 流感大流行中的爱情、甲状腺肿和死亡之谜。
IF 5.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-08-01 Epub Date: 2021-09-02 DOI: 10.1007/s40618-021-01668-4
J Jaksic, V Pandzic Jaksic

Ivan Mestrovic (1883-1962), a Croatian sculptor and architect, portrayed his close friend Marija Banac (born Racic) with a goiter. She died from flu in 1918 in Rome, just few days apart from her brother Edi Racic and his fiancée. In the tragic memory of the Racic family that disappeared in the burst of a terrible pandemic, Mestrovic built a church and mausoleum in Cavtat near Dubrovnik.

克罗地亚雕塑家和建筑师伊万·梅斯特罗维奇(1883-1962)描绘了他的密友玛丽亚·巴纳克(出生于拉西人)患甲状腺肿的形象。1918年,她在罗马死于流感,离她的哥哥埃迪·拉西克和他的未婚妻仅几天之遥。为了纪念在一场可怕的大流行病爆发中消失的拉希奇家族的悲惨记忆,梅斯特罗维奇在杜布罗夫尼克附近的卡夫塔特建造了一座教堂和陵墓。
{"title":"Mystery of love, goiter and death in flu pandemic.","authors":"J Jaksic,&nbsp;V Pandzic Jaksic","doi":"10.1007/s40618-021-01668-4","DOIUrl":"https://doi.org/10.1007/s40618-021-01668-4","url":null,"abstract":"<p><p>Ivan Mestrovic (1883-1962), a Croatian sculptor and architect, portrayed his close friend Marija Banac (born Racic) with a goiter. She died from flu in 1918 in Rome, just few days apart from her brother Edi Racic and his fiancée. In the tragic memory of the Racic family that disappeared in the burst of a terrible pandemic, Mestrovic built a church and mausoleum in Cavtat near Dubrovnik.</p>","PeriodicalId":15651,"journal":{"name":"Journal of Endocrinological Investigation","volume":"45 8","pages":"1605-1606"},"PeriodicalIF":5.4,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39380383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Which physical activity in patients affected by hypoparathyroidism? A review of the literature and practical recommendations. 甲状旁腺功能减退患者应进行哪些体力活动?文献综述和实用建议。
IF 5.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-07-01 Epub Date: 2022-02-05 DOI: 10.1007/s40618-022-01756-z
V Bonavolontà, L Cianferotti, G Iolascon, A Moretti, M L Brandi, F Fischetti, A Lenzi, C Baldari, S Migliaccio

Background: Hypoparathyroidism (HypoP) is a rare endocrine condition characterized by hypocalcaemia and hyperphosphatemia, as a consequence of absent or improperly low parathyroid hormone (PTH) levels. Patients affected by HypoP have a clinical condition often characterized by paresthesias and muscle spasms, as well as long-term consequences as nephrolithiasis, extraskeletal calcification, and fractures. In the literature, likely due to these symptoms, few data exist regarding the appropriate physical activity (PA) in subjects suffering from HypoP.

Purpose: This review evaluates the literature on exercise-based approaches to the management of individuals affected by HypoP and evaluates: (1) the effects of physical exercise on muscle cramps and other clinical symptoms; (2) the effects of exercise on PTH and calcium level; (3) the most suitable clinical exercise testing; and (4) the most suitable exercise combination.

Methods and results: A systematic search was conducted using the databases MEDLINE, Google Scholar using "hypoparathyroidism AND Physical Activity", "Training AND hypoparathyroidism", "Exercise AND muscle cramps", "Exercise AND Fatigue" as keywords. In addition, references list from the included articles were searched and cross-checked to identify any further potentially eligible studies. A total of 50 manuscripts were found among which 39 manuscripts were selected. A few clinical studies have been performed in HypoP patients to evaluate PA training protocols.

Conclusion: Although further research is needed to draw solid conclusions regarding best PA protocols in subjects affected by HypoP, a PA protocol has been proposed within the manuscript to encourage patients to attempt exercise to improve their clinical conditions and their quality of life.

背景:甲状旁腺功能减退症(HypoP)是一种罕见的内分泌疾病,以低钙血症和高磷血症为特征,是甲状旁腺激素(PTH)水平缺失或不适当降低的结果。HypoP患者的临床症状通常以感觉异常和肌肉痉挛为特征,长期后果包括肾结石、骨骼外钙化和骨折。在文献中,可能由于这些症状,关于HypoP患者适当的身体活动(PA)的数据很少。目的:本综述评估了以运动为基础的方法治疗HypoP患者的文献,并评估:(1)体育锻炼对肌肉痉挛和其他临床症状的影响;(2)运动对甲状旁腺激素和钙水平的影响;(3)最适合的临床运动试验;(4)最适合的运动组合。方法与结果:以“甲状旁腺功能减退与身体活动”、“训练与甲状旁腺功能减退”、“运动与肌肉痉挛”、“运动与疲劳”为关键词,利用MEDLINE、Google Scholar等数据库进行系统检索。此外,对纳入文献的参考文献列表进行检索和交叉核对,以确定任何进一步的潜在合格研究。共发现稿件50篇,入选稿件39篇。在HypoP患者中进行了一些临床研究,以评估PA训练方案。结论:虽然需要进一步的研究来得出关于受HypoP影响的受试者的最佳PA方案的可靠结论,但手稿中已经提出了一个PA方案,以鼓励患者尝试锻炼来改善他们的临床状况和生活质量。
{"title":"Which physical activity in patients affected by hypoparathyroidism? A review of the literature and practical recommendations.","authors":"V Bonavolontà,&nbsp;L Cianferotti,&nbsp;G Iolascon,&nbsp;A Moretti,&nbsp;M L Brandi,&nbsp;F Fischetti,&nbsp;A Lenzi,&nbsp;C Baldari,&nbsp;S Migliaccio","doi":"10.1007/s40618-022-01756-z","DOIUrl":"https://doi.org/10.1007/s40618-022-01756-z","url":null,"abstract":"<p><strong>Background: </strong>Hypoparathyroidism (HypoP) is a rare endocrine condition characterized by hypocalcaemia and hyperphosphatemia, as a consequence of absent or improperly low parathyroid hormone (PTH) levels. Patients affected by HypoP have a clinical condition often characterized by paresthesias and muscle spasms, as well as long-term consequences as nephrolithiasis, extraskeletal calcification, and fractures. In the literature, likely due to these symptoms, few data exist regarding the appropriate physical activity (PA) in subjects suffering from HypoP.</p><p><strong>Purpose: </strong>This review evaluates the literature on exercise-based approaches to the management of individuals affected by HypoP and evaluates: (1) the effects of physical exercise on muscle cramps and other clinical symptoms; (2) the effects of exercise on PTH and calcium level; (3) the most suitable clinical exercise testing; and (4) the most suitable exercise combination.</p><p><strong>Methods and results: </strong>A systematic search was conducted using the databases MEDLINE, Google Scholar using \"hypoparathyroidism AND Physical Activity\", \"Training AND hypoparathyroidism\", \"Exercise AND muscle cramps\", \"Exercise AND Fatigue\" as keywords. In addition, references list from the included articles were searched and cross-checked to identify any further potentially eligible studies. A total of 50 manuscripts were found among which 39 manuscripts were selected. A few clinical studies have been performed in HypoP patients to evaluate PA training protocols.</p><p><strong>Conclusion: </strong>Although further research is needed to draw solid conclusions regarding best PA protocols in subjects affected by HypoP, a PA protocol has been proposed within the manuscript to encourage patients to attempt exercise to improve their clinical conditions and their quality of life.</p>","PeriodicalId":15651,"journal":{"name":"Journal of Endocrinological Investigation","volume":"45 7","pages":"1289-1295"},"PeriodicalIF":5.4,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39588865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of Endocrinological Investigation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1